APA (7th ed.) Citation

Homšek Ilić, A., Jovanović, M., Marković, S., Vezmar Kovačević, S., Knežević Ivanovski, T., Kralj, Đ., . . . Vučićević, K. (2026). Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing. PLoS ONE, 21(7), 1. https://doi.org/10.1371/journal.pone.0352967

Chicago Style (17th ed.) Citation

Homšek Ilić, Ana, Marija Jovanović, Srđan Marković, Sandra Vezmar Kovačević, Tamara Knežević Ivanovski, Đorđe Kralj, Petar Svorcan, and Katarina Vučićević. "Pharmacokinetic Model Selection for Infliximab Based on Inflammatory Bowel Disease Phenotype and Severity: Toward Model-informed Precision Dosing." PLoS ONE 21, no. 7 (2026): 1. https://doi.org/10.1371/journal.pone.0352967.

MLA (9th ed.) Citation

Homšek Ilić, Ana, et al. "Pharmacokinetic Model Selection for Infliximab Based on Inflammatory Bowel Disease Phenotype and Severity: Toward Model-informed Precision Dosing." PLoS ONE, vol. 21, no. 7, 2026, p. 1, https://doi.org/10.1371/journal.pone.0352967.